Marlin HY22 profit down 86% as investment income collapses 81%

What changed

Reported revenue, which for this listed investment vehicle captures investment income and gains rather than trading revenue, fell 80.6% to NZ$6.3m from NZ$32.3m. Profit before tax collapsed 85.5% to NZ$4.2m and NPAT fell 86.1% to NZ$3.6m. Despite the earnings compression, operating cash flow swung to a NZ$5.3m inflow from a NZ$19.6m outflow in HY21, reflecting portfolio activity rather than trading performance. The balance sheet expanded: total equity rose 17.4% to NZ$242.1m and total liabilities fell 77.2% to NZ$1.1m. Cash on hand declined to NZ$4.5m from NZ$7.4m. The interim dividend was lifted 12.7% to 2.49 cents per share.

What matters

• Return on equity collapsed from 22.9% to 3.2%, the cleanest read on what happened: the portfolio's income and valuation gains were an order of magnitude smaller than the comparable period. PBT growth of -85.5% and NPAT growth of -86.1% are closely aligned (0.6pp gap), so PBT is the cleaner operating read and no tax distortion is at work, though the effective tax rate did rise from 9.9% to 13.8%.
• Dividend is not covered by current-period earnings. At the declared 2.49cps interim rate, the payout ratio versus HY22 NPAT is 132.4%, compared with 13.8% in HY21. This is the interim component only, not a full-period total, but the gap between the raised distribution and sharply lower earnings is the central tension in this release.
• Balance sheet is fortress-like but smaller in cash terms. Equity of NZ$242.1m sits against liabilities of just NZ$1.1m, so there is no leverage constraint on distributions. However, cash fell NZ$2.9m period-on-period, and sustained above-earnings payouts would have to come from accumulated reserves or portfolio realisations.

Expectations

No forward guidance, NTA target, or explicit return objective was disclosed in the supplied material. The only shape context is FY21, where HY21 represented just 41.3% of full-year revenue and 37.4% of full-year NPAT, implying a strongly second-half-weighted prior year (implied H2 FY21 NPAT of NZ$43.3m). Annualised HY22 revenue of NZ$12.5m sits far below the FY21 anchor of NZ$78.1m, so the current run-rate is materially below the prior full year unless second-half portfolio performance rebounds sharply. The release does not support a view either way on H2 shape; it only establishes that H1 started from a much weaker base.

Quality of result

For an investment vehicle, the "result" is largely market-driven and therefore inherently timing-sensitive rather than durable. Dividend income of NZ$0.2m (vs NZ$0.3m prior) indicates that underlying cash yield from the portfolio is modest and that most of the reported profit is tied to fair-value movements on investments. The positive operating cash flow of NZ$5.3m looks balance-sheet-assisted — it reflects the direction of portfolio transactions rather than a recurring cash-generating business, and the prior-period NZ$19.6m outflow is the counter-example. No non-GAAP adjustments, one-offs, or EBITDA reconciliation were disclosed, which removes some interpretive risk but also gives little to triangulate against. Working capital is immaterial at this scale.

Unresolved

• What drove the -80.6% swing in revenue: realised losses, unrealised mark-to-market on holdings, or a lower base of distributions received? The release does not decompose investment income versus gains.
• How does the raised interim dividend reconcile with the board's stated distribution policy, and is it funded from retained earnings, realisations, or capital?
• What is NTA per share now versus prior period, and what discount or premium does the share price trade at? No NTA was supplied.
• Why did total assets rise 15.2% to NZ$243.2m while cash fell NZ$2.9m — implying net portfolio deployment funded by something other than operating cash?

This briefing cannot assess portfolio composition, NTA per share, or the relationship between the current share price and underlying asset value, because none of that information was provided in the supplied extraction.

Key metrics

Analytical metrics

This analysis was generated using Annolyse, an AI-powered tool that analyses NZX company announcements. The analysis is based on available company filings and standard Annolyse calculations. This is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.